BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasonov EL, Popkova TV, Panafidina TA. Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic. Naučno-praktičeskaâ revmatologiâ 2021;59:119-128. [DOI: 10.47360/1995-4484-2021-119-128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Panafidina TA, Popkova TV, Lila AM. Incomplete systemic lupus erythematosus: terminology, diagnosis, course and therapy. jour 2022;100:447-455. [DOI: 10.30629/0023-2149-2022-100-9-10-447-455] [Reference Citation Analysis]
2 Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: history and modernity. Naučno-praktičeskaâ revmatologiâ 2022;60:397-412. [DOI: 10.47360/1995-4484-2022-397-412] [Reference Citation Analysis]
3 Nasonov EL, Lila AM, Dubinina TV, Nikininskaya OA, Amirdjanova VN. Advances in rheumatology at the beginning of the 21st century. Naučno-praktičeskaâ revmatologiâ 2022;60:5-20. [DOI: 10.47360/1995-4484-2022-5-20] [Reference Citation Analysis]
4 Nasonov EL, Belov BS, Lila AM, Aronova ES, Gridneva GI, Kudryavtseva AV, Sokol EV, Torgashina AV, Vinogradova IB, Abdulganieva DI, Zimenko AY. Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review. Naučno-praktičeskaâ revmatologiâ 2021;59:666-675. [DOI: 10.47360/1995-4484-2021-666-675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
5 Nasonov EL, Avdeeva AS, Popkova TV. New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor). Naučno-praktičeskaâ revmatologiâ 2021;59:537-546. [DOI: 10.47360/1995-4484-2021-537-546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nasonov EL, Lila AM, Mazurov VI, Belov BS, Karateev AE, Dubinina TV, Nikitinskaya OA, Baranov AA, Abdulganieva DI, Moiseev SV, Zagrebneva AI. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Naučno-praktičeskaâ revmatologiâ 2021;59:239-254. [DOI: 10.47360/1995-4484-2021-239-254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]